KM-023 clinical trials

Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome.

This study is testing a new medicine, KM-023, for Olmsted Syndrome. It first checks safety in healthy people, then looks at effects and safety in patients. It also studies how the body handles the medicine and how it affects the skin.